NCBiotech News

Morrisville-based Metabolon will collaborate with Mayo Clinic to develop novel metabolomic biomarkers for detecting various diseases.

RTP-based BioAesthetics has announced an additional clinical trial of its NACgraft, a biologically derived allograft for patients needing nipple reconstruction, to investigate its use of in male and female patients.

An FDA decision to grant broader emergency use authorization to Qorvo Biotechnologies’ COVID diagnostic test is significantly expanding the product’s reach.

Durham-based CytexOrtho is developing an innovative new implant technology to restore cartilage and bone in damaged or diseased joints that don’t normally heal on their own.

Raleigh-based Marius Pharmaceuticals has received federal approval for its first drug.

Durham biotech firm EpiCypher is dropping a patent infringement lawsuit against one of its main competitors, California-based Active Motif, to pursue a “mutual” cross-licensing agreement of their respective IP.

The North Carolina Biotechnology Center awarded 32 grants and loans totaling $3,304,543 to universities, bioscience companies and nonprofit organizations in the fourth quarter of its fiscal year.

Burlington-based Labcorp plans to spin off its wholly owned Clinical Development business as an independent, publicly traded company.

Indian pharmaceutical maker Ipca Laboratories Limited, parent company of Pisgah Labs in Western North Carolina, says it will spend $55 million to expand its manufacturing product line at the Transylvania County facility.

Dechra Pharmaceuticals of England is paying $210 million in cash to buy Greensboro-based Piedmont Animal Health, a successful NC startup bootstrapped with NCBiotech loan funding.

A research award program that Altis Biosystems introduced last year to encourage the use of its drug-development technology worked so well the company is at it again this year.

Business Facilities, a publication for corporate site selectors and economic developers, has designated North Carolina as having the best business climate in the nation, days after CNBC also named NC the country’s top state for business in 2022,

Leaders from public and private universities, businesses, nonprofits, trade associations and state government have joined forces to bring the new Advanced Research Projects Agency for Health headquarters to North Carolina.

North Carolina has been named by CNBC as “America’s Top State for Business in 2022.”

Burlington-based Labcorp has begun selling the first widely accessible test for direct evidence of neurodegeneration and neuronal injury.